Teva Pharmaceuticals USA, Inc.

États‑Unis d’Amérique

Retour au propriétaire

1-100 de 928 pour Teva Pharmaceuticals USA, Inc. Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 642
        Marque 286
Juridiction
        International 622
        États-Unis 221
        Europe 46
        Canada 39
Date
Nouveautés (dernières 4 semaines) 1
2025 mars 2
2025 janvier 5
2025 (AACJ) 7
2024 15
Voir plus
Classe IPC
A61P 35/00 - Agents anticancéreux 78
A61K 9/20 - Pilules, pastilles ou comprimés 47
C07D 471/04 - Systèmes condensés en ortho 28
C07D 487/04 - Systèmes condensés en ortho 27
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux 26
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 283
10 - Appareils et instruments médicaux 10
42 - Services scientifiques, technologiques et industriels, recherche et conception 2
35 - Publicité; Affaires commerciales 1
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 1
Statut
En Instance 213
Enregistré / En vigueur 715
  1     2     3     ...     10        Prochaine page

1.

TRUOZA

      
Numéro de série 99105594
Statut En instance
Date de dépôt 2025-03-26
Propriétaire TEVA PHARMACEUTICALS USA, INC. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders

2.

MIZKO

      
Numéro de série 99080422
Statut En instance
Date de dépôt 2025-03-12
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, injectable contraceptives; Oral contraceptives; Hormones for medical purposes

3.

HYBISCA

      
Numéro de série 98964638
Statut En instance
Date de dépôt 2025-01-15
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications

4.

ONHIRA

      
Numéro de série 98964641
Statut En instance
Date de dépôt 2025-01-15
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

5.

LIMHU

      
Numéro de série 98947900
Statut En instance
Date de dépôt 2025-01-09
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

6.

HUZALDA

      
Numéro de série 98947906
Statut En instance
Date de dépôt 2025-01-09
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

7.

DALHU

      
Numéro de série 98947907
Statut En instance
Date de dépôt 2025-01-09
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

8.

SIMLANDI (ADALIMUMAB-RYVK)

      
Numéro de série 98851706
Statut En instance
Date de dépôt 2024-11-13
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Pharmaceutical preparations for the treatment of autoimmune diseases Injectors for medical purposes, namely, medical fluid injectors

9.

GOMOSDI

      
Numéro d'application 019098808
Statut Enregistrée
Date de dépôt 2024-10-30
Date d'enregistrement 2025-03-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

10.

IMOSIPA

      
Numéro d'application 019098810
Statut Enregistrée
Date de dépôt 2024-10-30
Date d'enregistrement 2025-03-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

11.

GOSEMDO

      
Numéro d'application 019098824
Statut Enregistrée
Date de dépôt 2024-10-30
Date d'enregistrement 2025-03-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

12.

IMOSIPA FUSA

      
Numéro de série 98817999
Statut En instance
Date de dépôt 2024-10-24
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

13.

GOMOSDI FUSA

      
Numéro de série 98818002
Statut En instance
Date de dépôt 2024-10-24
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

14.

GOSEMDO VICI

      
Numéro de série 98818004
Statut En instance
Date de dépôt 2024-10-24
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

15.

GOMOSDI VICI

      
Numéro de série 98818012
Statut En instance
Date de dépôt 2024-10-24
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

16.

GOSEMDO FUSA

      
Numéro de série 98817992
Statut En instance
Date de dépôt 2024-10-24
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

17.

IMOSIPA VICI

      
Numéro de série 98818008
Statut En instance
Date de dépôt 2024-10-24
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

18.

ZINFAMEL

      
Numéro de série 98802332
Statut En instance
Date de dépôt 2024-10-15
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain; oral contraceptives and contraceptive preparations

19.

GOSEMDI

      
Numéro d'application 232058200
Statut En instance
Date de dépôt 2024-04-10
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of inflammatory and autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

20.

GOSEMDI

      
Numéro d'application 019011806
Statut Enregistrée
Date de dépôt 2024-04-10
Date d'enregistrement 2024-09-03
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of inflammatory and autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

21.

RIVELSA

      
Numéro de série 98446014
Statut Enregistrée
Date de dépôt 2024-03-12
Date d'enregistrement 2024-12-17
Propriétaire Teva Pharmaceuticals USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, oral contraceptives.

22.

PRE-FILLED SYRINGE

      
Numéro d'application 18382136
Statut En instance
Date de dépôt 2023-10-20
Date de la première publication 2024-02-08
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Inventeur(s)
  • Joguparthi, Vijay
  • Lobrutto, Rosario

Abrégé

An auto-injector device includes a pre-filled syringe including a container and a stainless steel needle adhered to the container with at least one of a urethane acrylate adhesive or a urethane methacrylate adhesive. The container is filled with at least 1 mL of a pharmaceutical composition comprising epinephrine, a buffer, and water, where the pharmaceutical composition has a pH ranging between 3 and 4. The auto-injector device also includes a firing mechanism that expels about 0.3 mL of the pharmaceutical composition from the container in less than 0.5 seconds during a single injection.

Classes IPC  ?

  • A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
  • C09J 175/16 - Polyuréthanes comportant des liaisons non saturées carbone-carbone comportant des liaisons non saturées carbone-carbone terminales
  • A61K 47/02 - Composés inorganiques
  • A61L 31/02 - Matériaux inorganiques
  • A61L 31/04 - Matériaux macromoléculaires
  • A61L 31/16 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques
  • A61M 5/20 - Seringues automatiques, p. ex. avec tige de piston actionnée automatiquement, avec injection automatique de l'aiguille, à remplissage automatique
  • A61M 5/31 - Seringues Parties constitutives
  • A61M 5/315 - PistonsTiges de pistonGuidage, blocage, ou limitation des mouvements de la tigeAccessoires disposés sur la tige pour faciliter le dosage
  • A61M 5/32 - AiguillesParties constitutives des aiguilles relatives au raccordement de celles-ci à la seringue ou au manchonAccessoires pour introduire l'aiguille dans le corps ou l'y maintenirDispositifs pour la protection des aiguilles
  • A61M 5/34 - Structures pour le raccordement de l'aiguille

23.

PROCESSES FOR THE PREPARATION OF FINERENONE

      
Numéro d'application US2023018968
Numéro de publication 2023/205164
Statut Délivré - en vigueur
Date de dépôt 2023-04-18
Date de publication 2023-10-26
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Rengasamy, Vadivelan
  • Ariyamuthu, Sundaraselvan
  • Mandewale, Mustapha
  • Subbireddy, Elluru
  • Kapoor, Gaurav
  • Mukherjee, Soumya
  • Nighot, Dnyaneshwar
  • Kushwaha, Sandeep Kumar

Abrégé

The present disclosure encompasses processes for the preparation of (S)-Finerenone.

Classes IPC  ?

  • C07D 401/04 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une liaison directe de chaînon cyclique à chaînon cyclique

24.

SOLID STATE FORMS OF LX9211 AND SALTS THEREOF

      
Numéro d'application US2023015992
Numéro de publication 2023/183443
Statut Délivré - en vigueur
Date de dépôt 2023-03-23
Date de publication 2023-09-28
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Škalec Šamec, Dijana
  • Karadakić, Klara
  • Barbaro, Tea
  • Landeka, Ivana

Abrégé

The present disclosure encompasses solid state forms of LX9211, salts and cocrystals thereof, in embodiments processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 213/65 - Un atome d'oxygène lié en position 3 ou 5
  • A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
  • A61K 31/444 - Pyridines non condenséesLeurs dérivés hydrogénés contenant d'autres systèmes hétérocycliques contenant un cycle à six chaînons avec l'azote comme hétéro-atome du cycle, p. ex. amrinone

25.

SOLID STATE FORMS OF TOLEBRUTINIB AND OF TOLEBRUTINIB SALTS

      
Numéro d'application US2023014868
Numéro de publication 2023/172663
Statut Délivré - en vigueur
Date de dépôt 2023-03-09
Date de publication 2023-09-14
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s) Kordić, Lorena

Abrégé

The present disclosure encompasses solid state forms of Tolebrutinib and of Tolebrutinib salts, in embodiments crystalline polymorphs of Tolebrutinib and of Tolebrutinib salts, processes for preparation thereof, and pharmaceutical compositions thereof. In particular, the present invention discloses crystalline polymorphs, salts and co-crystals of Tolebrutinib.

Classes IPC  ?

  • C07D 471/04 - Systèmes condensés en ortho
  • A61P 35/00 - Agents anticancéreux
  • A61K 31/437 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle condensés en ortho ou en péri avec des systèmes hétérocycliques le système hétérocyclique contenant un cycle à cinq chaînons ayant l'azote comme hétéro-atome du cycle, p. ex. indolizine, bêta-carboline

26.

SOLID STATE FORMS OF SELTOREXANT

      
Numéro d'application US2023013572
Numéro de publication 2023/163964
Statut Délivré - en vigueur
Date de dépôt 2023-02-22
Date de publication 2023-08-31
Propriétaire
  • TEVA CZECH INDUSTRIES S.R.O. (République tchèque)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Kolesa, Pavel
  • Przeczková, Zuzana
  • Bártová, Adéla
  • Romanová, Jana

Abrégé

Solid state forms of Seltorexant HCl and processes for preparation thereof, and pharmaceutical compositions thereof are disclosed.

Classes IPC  ?

  • C07D 487/12 - Composés hétérocycliques contenant des atomes d'azote comme uniques hétéro-atomes dans le système condensé, non prévus par les groupes dans lesquels le système condensé contient trois hétérocycles
  • A61P 25/24 - Antidépresseurs

27.

CRYSTALLINE FORMS OF TRILACICLIB AND TRILACICLIB SALTS

      
Numéro d'application US2023014031
Numéro de publication 2023/164255
Statut Délivré - en vigueur
Date de dépôt 2023-02-28
Date de publication 2023-08-31
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Muthusamy, Anantha Rajmohan
  • Putikum, Rahul Kumar Reddy
  • Rengaraj, Prathap
  • Singh, Amit
  • Kadu, Rushikesh Vilasrao
  • Singh, Satnam

Abrégé

The present disclosure encompasses solid state forms of Trilaciclib and Trilaciclib citrate salt, in embodiments polymorphs of Trilaciclib and Trilaciclib citrate salt, processes for preparation thereof, pharmaceutical compositions and uses thereof.

Classes IPC  ?

  • A61P 35/00 - Agents anticancéreux
  • C07D 487/20 - Systèmes condensés en spiro
  • A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles

28.

SOLID STATE FORMS OF GUSACITINIB

      
Numéro d'application US2023013668
Numéro de publication 2023/164024
Statut Délivré - en vigueur
Date de dépôt 2023-02-23
Date de publication 2023-08-31
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit
  • Singh, Chanchal
  • Rengaraj, Prathap

Abrégé

The present disclosure encompasses solid state forms of Gusacitinib, in embodiments crystalline polymorphs of Gusacitinib, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 487/04 - Systèmes condensés en ortho
  • A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
  • A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
  • A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques

29.

SOLID STATE FORMS OF DANICOPAN AND PROCESS THEREOF

      
Numéro d'application US2023013270
Numéro de publication 2023/158772
Statut Délivré - en vigueur
Date de dépôt 2023-02-17
Date de publication 2023-08-24
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Muthusamy, Anantha Rajmohan
  • Somasundaram, Meenakshi Sundaram

Abrégé

The present disclosure relates to Danicopan solid state forms, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

Classes IPC  ?

  • C07D 403/14 - Composés hétérocycliques contenant plusieurs hétérocycles, comportant des atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant au moins trois hétérocycles
  • A61K 31/506 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime non condensées et contenant d'autres hétérocycles
  • A61P 7/00 - Médicaments pour le traitement des troubles du sang ou du fluide extracellulaire

30.

PROCESSES FOR PREPARATION OF AVACOPAN AND INTERMEDIATES THEREOF

      
Numéro d'application US2023013189
Numéro de publication 2023/158722
Statut Délivré - en vigueur
Date de dépôt 2023-02-16
Date de publication 2023-08-24
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Gyűjtő, Imre
  • Paál, Tihamér
  • Juhász, Zsuzsa Pótáriné
  • Eszenyi, Dániel
  • Zahuczky, Gábor József
  • Kondor, Zoltán
  • Rengasamy, Vadivelan
  • Prajapaty, Ramkaran
  • Daund, Vaibhav Suresh
  • Sainger, Shachi
  • Kadu, Rushikesh
  • Sharma, Vishal

Abrégé

The present disclosure encompasses a process for chiral resolution of racemic amines, particularly ethyl 2-(4-((tert-butoxycarbonyl)amino)phenyl)piperidine-3-carboxylate, into its desired isomer, ethyl (2R,3S)-2-(4-((tert-butoxycarbonyl)amino)phenyl)-piperidine-3-carboxylate, which is an intermediate useful in the synthesis of Avacopan.

Classes IPC  ?

  • C12P 13/00 - Préparation de composés organiques contenant de l'azote
  • C12P 17/12 - Préparation de composés hétérocycliques comportant O, N, S, Se ou Te comme uniques hétéro-atomes du cycle l'azote comme unique hétéro-atome du cycle contenant un hétérocycle à six chaînons
  • C12N 9/06 - Oxydoréductases (1.), p. ex. luciférase agissant sur des composés contenant de l'azote comme donneurs (1.4, 1.5, 1.7)
  • C07D 221/00 - Composés hétérocycliques contenant des cycles à six chaînons ne comportant qu'un atome d'azote comme unique hétéro-atome du cycle, non prévus par les groupes

31.

CONNECTD

      
Numéro de série 98135426
Statut Enregistrée
Date de dépôt 2023-08-16
Date d'enregistrement 2024-12-24
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Medical services, namely, providing information relating to tardive dyskinesia to medical and health care professionals

32.

COVLA

      
Numéro de série 98130997
Statut En instance
Date de dépôt 2023-08-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

33.

SOLID STATE FORMS OF TIPIFARNIB AND PROCESS FOR PREPARATION THEREOF

      
Numéro d'application US2023010894
Numéro de publication 2023/141082
Statut Délivré - en vigueur
Date de dépôt 2023-01-17
Date de publication 2023-07-27
Propriétaire
  • TEVA CZECH INDUSTRIES S.R.O. (République tchèque)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit
  • Rengaraj, Prathap

Abrégé

The present disclosure encompasses solid state forms of Tipifarnib, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 401/06 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une chaîne carbonée contenant uniquement des atomes de carbone aliphatiques
  • A61P 35/00 - Agents anticancéreux
  • A61K 31/4704 - 2-Quinolones, p. ex. carbostyrile
  • A61K 31/4709 - Quinoléines non condensées contenant d'autres hétérocycles

34.

SOLID STATE FORMS OF RUCAPARIB TOSYLATE

      
Numéro d'application US2023010592
Numéro de publication 2023/137060
Statut Délivré - en vigueur
Date de dépôt 2023-01-11
Date de publication 2023-07-20
Propriétaire
  • ASSIA CHEMICAL INDUSTRIES LTD. (Israël)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Škalec Šamec, Dijana
  • Travančić, Valentina
  • Šahnić, Damir

Abrégé

The present disclosure encompasses solid state forms of Rucaparib Tosylate, and pharmaceutical compositions thereof.

Classes IPC  ?

  • A61P 35/00 - Agents anticancéreux
  • A61K 31/55 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole
  • C07D 487/04 - Systèmes condensés en ortho

35.

IMPROVED PROCESSES FOR THE PREPARATION OF RIPRETINIB

      
Numéro d'application US2022053916
Numéro de publication 2023/122322
Statut Délivré - en vigueur
Date de dépôt 2022-12-23
Date de publication 2023-06-29
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Luthra, Parven Kumar
  • Sinha, Chandrasekhar
  • Arote, Nitin Dnyaneshwar
  • Pandey, Anand Kumar
  • Tyagi, Bhupendra Prakash
  • Sonar, Jitendra Kamalakar
  • Jaiswal, Sanjay
  • Mistry, Maulik Dipakbhai

Abrégé

The present invention relates to safe and improved processes for the preparation of substantially pure intermediates of formula Va and their use in the synthesis of Ripretinib and salts thereof.

Classes IPC  ?

36.

SOLID STATE FORMS OF LOTILANER AND PROCESS FOR PREPARATION THEREOF

      
Numéro d'application US2022052335
Numéro de publication 2023/107660
Statut Délivré - en vigueur
Date de dépôt 2022-12-09
Date de publication 2023-06-15
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit

Abrégé

The present disclosure encompasses a solid-state form of Lotilaner, in embodiment processes for preparation thereof, and pharmaceutical compositions thereof. The present disclosure further encompasses Lotilaner salts and their solid state forms, as well as processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 413/04 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes d'azote et d'oxygène comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une liaison directe de chaînon cyclique à chaînon cyclique
  • A61K 31/422 - Oxazoles non condensés et contenant d'autres hétérocycles
  • A61P 27/00 - Médicaments pour traiter les troubles des sens
  • A61P 31/00 - Agents anti-infectieux, c.-à-d. antibiotiques, antiseptiques, chimiothérapeutiques

37.

FIDALTO

      
Numéro de série 98041823
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

38.

BRAVAYIS

      
Numéro de série 98041825
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

39.

NEOLESK

      
Numéro de série 98041827
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

40.

LONGAVO

      
Numéro de série 98041822
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

41.

ZELVRI

      
Numéro de série 98041833
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

42.

TIZAYA

      
Numéro de série 98041838
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

43.

QVOSO

      
Numéro d'application 226316900
Statut En instance
Date de dépôt 2023-06-09
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders, namely, Huntington's disease, cerebral palsy, myasthenia gravia, brain injury, spinal cord injury, seizure disorders.

44.

SOLID STATE FORMS OF DEUCRAVACITINIB, DEUCRAVACITINIB HCL AND PROCESS FOR PREPARATION OF DEUCRAVACITINIB AND INTERMEDIATES

      
Numéro d'application US2022051466
Numéro de publication 2023/102085
Statut Délivré - en vigueur
Date de dépôt 2022-12-01
Date de publication 2023-06-08
Propriétaire
  • TEVA CZECH INDUSTRIES S.R.O. (République tchèque)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Šagud, Ivana
  • Biljan, Tomislav
  • Samardzic, Zrinka Mastelic
  • Dancevic Momcilovic, Tina
  • Ljubic, Anabela
  • Kos, Marija
  • Škalec Šamec, Dijana
  • Travančić, Valentina

Abrégé

The present disclosure encompasses solid state forms of Deucravacitinib : L- tartaric acid or Deucravacitinib - L-tartrate, as well as processes for preparation of Deucravacitinib and intermediates thereof.

Classes IPC  ?

  • C07D 403/12 - Composés hétérocycliques contenant plusieurs hétérocycles, comportant des atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons

45.

SOLID STATE FORMS OF TAVAPADON AND PROCESSES FOR PREPARATION THEREOF

      
Numéro d'application US2022051470
Numéro de publication 2023/102087
Statut Délivré - en vigueur
Date de dépôt 2022-12-01
Date de publication 2023-06-08
Propriétaire
  • TEVA CZECH INDUSTRIES S.R.O (République tchèque)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Przeczková, Zuzana
  • Bártová, Adéla
  • Kolesa, Pavel
  • Jegorov, Alexandr
  • Romanová, Jana

Abrégé

The present disclosure encompasses solid state forms of Tavapadon, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 401/12 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • A61P 25/16 - Antiparkinsoniens
  • A61K 31/444 - Pyridines non condenséesLeurs dérivés hydrogénés contenant d'autres systèmes hétérocycliques contenant un cycle à six chaînons avec l'azote comme hétéro-atome du cycle, p. ex. amrinone

46.

SOLID STATE FORMS OF NIROGACESTAT SALTS

      
Numéro d'application US2022050833
Numéro de publication 2023/096954
Statut Délivré - en vigueur
Date de dépôt 2022-11-23
Date de publication 2023-06-01
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit

Abrégé

The present disclosure encompasses solid state forms of Nirogacestat salts, in embodiments crystalline polymorphs of Nirogacestat salts, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

47.

SOLID STATE FORM OF TAFAMIDIS

      
Numéro d'application US2022050182
Numéro de publication 2023/091534
Statut Délivré - en vigueur
Date de dépôt 2022-11-17
Date de publication 2023-05-25
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Matecic Musanic, Sanja
  • Travancic, Valentina
  • Pavlicic, Dubravka
  • Ratkaj, Marina

Abrégé

The present disclosure relates to a solid state form of Tafamidis, processes for preparation thereof and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 263/57 - Radicaux aryle ou aryle substitués
  • A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
  • A61K 31/423 - Oxazoles condensés avec des carbocycles

48.

SOLID STATE FORMS OF ENSIFENTRINE AND PROCESS FOR PREPARATION THEREOF

      
Numéro d'application US2022047642
Numéro de publication 2023/076205
Statut Délivré - en vigueur
Date de dépôt 2022-10-25
Date de publication 2023-05-04
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Muthusamy, Anantha Rajmohan
  • Putikum, Rahul Kumar Reddy

Abrégé

The present disclosure encompasses solid state forms of Ensifentrine, in embodiments crystalline polymorphs or salts of Ensifentrine, particularly Ensifentrine ethane-1,2-disulfonate, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 471/04 - Systèmes condensés en ortho
  • A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
  • A61P 37/08 - Agents antiallergiques
  • A61P 11/06 - Antiasthmatiques

49.

BEAUTESSE

      
Numéro de série 97918608
Statut En instance
Date de dépôt 2023-05-03
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Contraceptive preparations; pharmaceutical preparations for use in the treatment of fertility disorders, hormone replacement, menopause

50.

SOLID STATE FORMS OF ELACESTRANT AND PROCESSES FOR PREPARATION THEREOF

      
Numéro d'application US2022046645
Numéro de publication 2023/064519
Statut Délivré - en vigueur
Date de dépôt 2022-10-14
Date de publication 2023-04-20
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Kordic, Lorena
  • Travancic, Valentina
  • Landeka, Ivana
  • Janton, Nikolina

Abrégé

The present invention concerns a co-crystal of Elacestrant dihydrochloride and urea, its use in the preparation of another solid state form of Elecestrant or a salt thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07C 217/84 - Composés contenant des groupes amino et hydroxy éthérifiés liés au même squelette carboné ayant des groupes amino et des groupes hydroxy éthérifiés liés à des atomes de carbone de cycles aromatiques à six chaînons du même squelette carboné ayant des groupes amino et des groupes hydroxy éthérifiés liés à des atomes de carbone de cycles aromatiques à six chaînons non condensés du même cycle aromatique à six chaînons non condensé l'atome d'oxygène d'au moins un des groupes hydroxy éthérifiés étant lié de plus à un atome de carbone acyclique
  • C07C 275/02 - SelsComplexesComposés d'addition
  • A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
  • A61K 31/17 - Amides, p. ex. acides hydroxamiques ayant le groupe N-C(O)-N ou N-C(S)-N, p. ex. urée, thiourée, carmustine
  • A61P 35/00 - Agents anticancéreux

51.

WELTRUZA

      
Numéro de série 97896396
Statut En instance
Date de dépôt 2023-04-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

52.

SUPELLIA

      
Numéro de série 97896217
Statut En instance
Date de dépôt 2023-04-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

53.

TRINQUIS

      
Numéro de série 97896222
Statut En instance
Date de dépôt 2023-04-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

54.

DEMTEGE

      
Numéro de série 97896225
Statut En instance
Date de dépôt 2023-04-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

55.

YOU OWN THE DAY NOT TD

      
Numéro de série 97888337
Statut En instance
Date de dépôt 2023-04-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical products for treatment of neurological diseases Pharmaceutical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases; medical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases

56.

YOU OWN THE DAY NOT HD CHOREA

      
Numéro de série 97888340
Statut En instance
Date de dépôt 2023-04-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical products for treatment of neurological diseases Pharmaceutical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases; medical research services, namely, research relating to pharmaceutical products for the treatment of neurological diseases

57.

ADHUMA

      
Numéro d'application 018859176
Statut Enregistrée
Date de dépôt 2023-04-06
Date d'enregistrement 2023-08-19
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology.

58.

ACCEMPA

      
Numéro d'application 018859244
Statut Enregistrée
Date de dépôt 2023-04-06
Date d'enregistrement 2023-08-18
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

59.

ADHUMA

      
Numéro d'application 224997000
Statut En instance
Date de dépôt 2023-04-05
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology.

60.

ABEQUO

      
Numéro d'application 224996800
Statut En instance
Date de dépôt 2023-04-05
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

61.

ACCEMPA

      
Numéro de série 97873904
Statut En instance
Date de dépôt 2023-04-05
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

62.

SOLID STATE FORMS OF IPATASERTIB CITRATE

      
Numéro d'application US2022043579
Numéro de publication 2023/043869
Statut Délivré - en vigueur
Date de dépôt 2022-09-15
Date de publication 2023-03-23
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Škalec Šamec, Dijana
  • Karadakić, Klara

Abrégé

The present invention encompasses salts and solid state forms of Ipatasertib and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 239/70 - Composés hétérocycliques contenant des cycles diazine-1, 3 ou diazine-1, 3 hydrogéné condensés avec des carbocycles ou avec des systèmes carbocycliques
  • A61P 35/00 - Agents anticancéreux
  • A61K 31/517 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des systèmes carbocycliques, p. ex. quinazoline, périmidine

63.

SOLID STATE FORMS OF VERICIGUAT AND PROCESS FOR PREPARATION THEREOF

      
Numéro d'application US2022042129
Numéro de publication 2023/034364
Statut Délivré - en vigueur
Date de dépôt 2022-08-31
Date de publication 2023-03-09
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Katsav, Luna Ben-Sahel
  • Goldshtein, Jenny
  • Adani, Limor
  • Masarwa, Abed
  • Muthusamy, Anantha Rajmohan
  • Somasundaram, Meenakshi Sundaram
  • Muppalla, Siva Rama Krishna
  • Pandey, Anand Kumar
  • Sonar, Jitendra Kamalakar
  • Kumar, Sumit

Abrégé

The present disclosure encompasses solid state forms of Vericiguat, in embodiments crystalline polymorphs of Vericiguat, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 471/04 - Systèmes condensés en ortho
  • A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
  • A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire

64.

POLYMORPHS OF PONESIMOD

      
Numéro d'application US2022039770
Numéro de publication 2023/022896
Statut Délivré - en vigueur
Date de dépôt 2022-08-09
Date de publication 2023-02-23
Propriétaire
  • TEVA CZECH INDUSTRIES S.R.O (République tchèque)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Patel, Rohit Dwarkabhai
  • Borase, Vinod Ramesh
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit

Abrégé

The present disclosure encompasses Ponesimod crystalline forms, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 277/54 - Atomes d'azote combinés soit à des atomes d'oxygène, soit à des atomes de soufre
  • A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques
  • A61K 31/426 - 1,3-Thiazoles

65.

LOGILIA

      
Numéro de série 97794282
Statut En instance
Date de dépôt 2023-02-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

66.

JOURNESS

      
Numéro de série 97794287
Statut En instance
Date de dépôt 2023-02-14
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

67.

CAMRESE

      
Numéro de série 97778192
Statut Enregistrée
Date de dépôt 2023-02-02
Date d'enregistrement 2024-02-20
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents for treating disorders and conditions related to women's health

68.

BEAUTESSE

      
Numéro de série 97774835
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

69.

PONSYMDI

      
Numéro de série 97774843
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

70.

IMOSIPA

      
Numéro de série 97774845
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

71.

GOSEMDO

      
Numéro de série 97774849
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

72.

GOSEMDA

      
Numéro de série 97774850
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

73.

GOMOSDI

      
Numéro de série 97774855
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

74.

GOLMPODI

      
Numéro de série 97774857
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

75.

SIPLIMU

      
Numéro de série 97774867
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

76.

CHAKRA

      
Numéro de série 97774841
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations, namely, oral and injectable contraceptives; women's hormone replacement therapy preparations

77.

EMZIPODI

      
Numéro de série 97774860
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

78.

SMIODI

      
Numéro de série 97774864
Statut En instance
Date de dépôt 2023-01-31
Propriétaire TEVA PHARMACEUTICALS USA, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

79.

SOLID STATE FORMS OF AMCENESTRANT

      
Numéro d'application US2022037052
Numéro de publication 2023/287938
Statut Délivré - en vigueur
Date de dépôt 2022-07-14
Date de publication 2023-01-19
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Kordić, Lorena
  • Matečić Mušanić, Sanja
  • Barbaro, Tea

Abrégé

The present disclosure encompasses solid state forms of Amcenestrant, in embodiments crystalline polymorphs of Amcenestrant, processes for preparation thereof, and pharmaceutical compositions thereof.

Classes IPC  ?

  • C07D 207/12 - Atomes d'oxygène ou de soufre
  • A61P 35/00 - Agents anticancéreux
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil

80.

Ralpoi

      
Numéro d'application 018822086
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

81.

Osjuvma

      
Numéro d'application 018823129
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

82.

Geovma

      
Numéro d'application 018823130
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

83.

DENPODSU

      
Numéro d'application 018823169
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

84.

POZUDEMA

      
Numéro d'application 018823471
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

85.

Podusma

      
Numéro d'application 018823486
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

86.

Podenmo

      
Numéro d'application 018822087
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

87.

PONLIMSI

      
Numéro d'application 018822088
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

88.

Dejevma

      
Numéro d'application 018823163
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

89.

Denjevma

      
Numéro d'application 018823188
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

90.

Xavejma

      
Numéro d'application 018823465
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

91.

Yejexma

      
Numéro d'application 018823467
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

92.

Poduzma

      
Numéro d'application 018823484
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

93.

Denpodma

      
Numéro d'application 018823488
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

94.

Podsuma

      
Numéro d'application 018823489
Statut Enregistrée
Date de dépôt 2023-01-13
Date d'enregistrement 2023-05-17
Propriétaire TEVA PHARMACEUTICALS USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of bone diseases, excluding bone cancer.

95.

SOLID STATE FORMS OF 4-[[4-(4-CHLOROANILINO)FURO[2,3-D]PYRIDAZIN-7- YL]OXYMETHYL]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND SALT THEREOF

      
Numéro d'application US2022035413
Numéro de publication 2023/283080
Statut Délivré - en vigueur
Date de dépôt 2022-06-29
Date de publication 2023-01-12
Propriétaire
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Suisse)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventeur(s)
  • Luthra, Parven Kumar
  • Muthusamy, Anantha Rajmohan
  • Somasundaram, Meenakshi Sundaram
  • Putikum, Rahul Kumar Reddy

Abrégé

The present disclosure relates to solid state forms of Telatinib and Telatinib mesylate, processes for their preparation, and pharmaceutical compositions thereof (I).

Classes IPC  ?

  • C07D 491/048 - Systèmes condensés en ortho avec un seul atome d'oxygène comme hétéro-atome du cycle contenant de l'oxygène le cycle contenant de l'oxygène étant à cinq chaînons

96.

OSJUVMA

      
Numéro d'application 223272200
Statut En instance
Date de dépôt 2023-01-10
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

97.

DENJEVMA

      
Numéro d'application 223272300
Statut En instance
Date de dépôt 2023-01-10
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

98.

GEOVMA

      
Numéro d'application 223272500
Statut En instance
Date de dépôt 2023-01-10
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

99.

XAVEJMA

      
Numéro d'application 223272600
Statut En instance
Date de dépôt 2023-01-10
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

100.

YEJEXMA

      
Numéro d'application 223272700
Statut En instance
Date de dépôt 2023-01-10
Propriétaire Teva Pharmaceuticals USA, Inc. (USA)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.
  1     2     3     ...     10        Prochaine page